Cargando…
Thymoquinone-Induced Reactivation of Tumor Suppressor Genes in Cancer Cells Involves Epigenetic Mechanisms
The epigenetic silencing of tumor suppressor genes (TSGs) is a common finding in several solid and hematological tumors involving various epigenetic readers and writers leading to enhanced cell proliferation and defective apoptosis. Thymoquinone (TQ), the major biologically active compound of black...
Autores principales: | Qadi, Shahad A, Hassan, Mohammed A, Sheikh, Ryan A, Baothman, Othman AS, Zamzami, Mazin A, Choudhry, Hani, Al-Malki, Abdulrahman Labeed, Albukhari, Ashwag, Alhosin, Mahmoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452588/ https://www.ncbi.nlm.nih.gov/pubmed/31058255 http://dx.doi.org/10.1177/2516865719839011 |
Ejemplares similares
-
Thymoquinone challenges UHRF1 to commit auto-ubiquitination: a key event for apoptosis induction in cancer cells
por: Ibrahim, Abdulkhaleg, et al.
Publicado: (2018) -
Thymoquinone and Difluoromethylornithine (DFMO) Synergistically Induce Apoptosis of Human Acute T Lymphoblastic Leukemia Jurkat Cells Through the Modulation of Epigenetic Pathways
por: Alhosin, Mahmoud, et al.
Publicado: (2020) -
Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer
por: Alhosin, Mahmoud, et al.
Publicado: (2016) -
Untargeted Metabolomics Identifies Key Metabolic Pathways Altered by Thymoquinone in Leukemic Cancer Cells
por: AlGhamdi, Asma Ahmed, et al.
Publicado: (2020) -
Targeting microRNA/UHRF1 pathways as a novel strategy for cancer therapy
por: Choudhry, Hani, et al.
Publicado: (2018)